J B Chemicals & Pharmaceuticals Ltd Analyst Rating
based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts offering long term price targets for J B Chemicals & Pharmaceuticals Ltd. An average target of ₹2173.77
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Share analysis
J B Chemicals & Pharmaceuticals Ltd price forecast by 13 analysts
Upside of25.27%
High
₹2330
Target
₹2173.77
Low
₹1686
J B Chemicals & Pharmaceuticals Ltd target price ₹2173.77, a slight upside of 25.27% compared to current price of ₹1759.1. According to 13 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
J B Chemicals & Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2026:30.78%
Forecast
Actual
Including amortisation and stock based compensations
J B Chemicals & Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2026:55.83%
Forecast
Actual
Source: S&P Global Market Intelligence
J B Chemicals & Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹1,734₹1,769.752 Week's Low
52 Week's High
₹1,393₹2,030
| Returns % | |
| 1 Month Return | -6.24 % |
| 3 Month Return | -11.94 % |
| 1 Year Return | + 17.94 % |
| Market Stats | |
| Previous Close | ₹1,735.30 |
| Open | ₹1,736.00 |
| Volume | 1.61L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹26,968.25Cr |
J B Chemicals & Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 43.97 |
| PEG Ratio | 3.48 |
| Market Cap | ₹26,968.25 Cr |
| P/B Ratio | 8.87 |
| EPS | 35.61 |
| Dividend Yield | 0.74 |
| Sector | Pharmaceuticals |
| ROE | 20.39 |
J B Chemicals & Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹26,968.25 Cr | 153.03% | 0.56 | ₹552 Cr | ₹3,484 Cr | |
| HOLD | ₹33,241.09 Cr | 134.96% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
| BUY | ₹19,661.60 Cr | 35.83% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹7,024.92 Cr | 7.7% | 0.79 | -₹388 Cr | ₹75 Cr | |
| BUY | ₹16,140.62 Cr | 50.61% | 0.68 | ₹218 Cr | ₹1,296 Cr |
J B Chemicals & Pharmaceuticals Ltd Mutual Fund Holdings
About J B Chemicals & Pharmaceuticals Ltd
Share Price: ₹1759.10 per share as on 02 Dec, 2024 04:01 PM
Market Capitalisation: ₹26,968.25Cr as of today
Revenue: ₹1,000.62Cr as on September 2024 (Q3 24)
Net Profit: ₹174.57Cr as on September 2024 (Q3 24)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
| Organisation | J B Chemicals & Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for J B Chemicals & Pharmaceuticals Ltd
J B Chemicals Stock Rises for Third Session - 25 Nov, 2024
J B Chemicals & Pharmaceuticals Ltd is up 1.58% at Rs 1770.95, marking its third consecutive session of gains. The stock has increased 27.15% over the past year, despite a 5.27% decline in the last month. Trading volume today is lower than the monthly average.J.B. Chemicals Maintains Buy Rating with Target Price - 11 Nov, 2024
Prabhudas Lilladher maintains a BUY rating on J.B. Chemicals & Pharmaceuticals with a target price of Rs 2,250. The company shows strong growth potential driven by geographical expansion, improved MR productivity, and new product launches, with an expected EPS CAGR of 24% over FY24-27E.JB Chemicals Reports Strong Q2 2024 Financials - 07 Nov, 2024
JB Chemicals reported consolidated net sales of Rs 1,000.62 crore for September 2024, a 13.48% increase year-on-year. Net profit rose 15.92% to Rs 174.57 crore, with EBITDA up 11.65%. The EPS increased to Rs 11.24. Shares closed at Rs 1,880.70, reflecting a 33.04% gain over the past year.KKR Considers Selling Stake in JB Chemicals - 06 Nov, 2024
KKR & Co is contemplating a sale of its controlling stake in JB Chemicals & Pharmaceuticals, potentially worth $750 million to $1 billion. The firm may reduce its stake from nearly 54% to about 25%. Shares of JB Pharma have surged 16% this year, reflecting strong investor interest. KKR's stake sale could occur in the coming weeks, with no final decisions made yet.
Insights on J B Chemicals & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 851.86 Cr → 1.01K Cr (in ₹), with an average increase of 5.4% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 12.17% to 13.63% in Sep 2024 quarter
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 53.77% to 53.74% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 16.43% to 15.81% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, JBCHEPHARM stock has moved down by -1.1%
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 15.04% to 14.60% in Sep 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 176.83 Cr → 174.57 Cr (in ₹), with an average decrease of 1.3% per quarter
J B Chemicals & Pharmaceuticals Ltd Financials
Index Inclusions
J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.74% | ||
| Foreign Institutions | 13.63% | 12.03 | |
| Mutual Funds | 14.6% | ||
| Retail Investors | 15.81% | ||
| Others | 2.21% |
J B Chemicals & Pharmaceuticals Ltd Key Indicators
J B Chemicals & Pharmaceuticals Ltd Valuation
J B Chemicals & Pharmaceuticals Ltd in the last 5 years
Lowest (10.61x)
October 24, 2019
Today (43.97x)
November 29, 2024
Industry (55.31x)
November 29, 2024
Highest (62.92x)
February 7, 2024
J B Chemicals & Pharmaceuticals Ltd Earnings and Dividends
J B Chemicals & Pharmaceuticals Ltd Earnings Results
J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 15.92% since last year same period to ₹174.57Cr in the Q2 2024-2025. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -1.28% fall in its net profits since last 3-months.
Read More about Earnings ResultsJ B Chemicals & Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, J B Chemicals & Pharmaceuticals Ltd has declared dividend of ₹6.75 - translating a dividend yield of 1.24%.
Read More about Dividends
J B Chemicals & Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
J B Chemicals & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on J B Chemicals & Pharmaceuticals Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy J B Chemicals & Pharmaceuticals Ltd shares.
J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price today is ₹1759.1
J B Chemicals & Pharmaceuticals Ltd is listed on NSE
J B Chemicals & Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of J B Chemicals & Pharmaceuticals Ltd is ₹1769.7.
- Today’s lowest price of J B Chemicals & Pharmaceuticals Ltd is ₹1734.
PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 43.97
PE ratio = J B Chemicals & Pharmaceuticals Ltd Market price per share / J B Chemicals & Pharmaceuticals Ltd Earnings per share
Today’s traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 1.61L.
Today’s market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹26968.25Cr.
| J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Price |
|---|---|
52 Week High | ₹2030 |
52 Week Low | ₹1393 |
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1759.1. It is down -13.34% from its 52 Week High price of ₹2030
J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) share price is ₹1759.1. It is up 26.28% from its 52 Week Low price of ₹1393
| J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM | Returns |
|---|---|
1 Day Returns | 23.8% |
1 Month Returns | -6.24% |
3 Month Returns | -11.94% |
1 Year Returns | 17.94% |